Replies to post #417909 on Amarin Corp Plc (AMRN)

[sts66]

I'm pretty sure NVAX is still losing money, never had a profitable quarter despite the OWS windfall - delays in getting the vaccine made killed them, lots of money wasted on upgrading existing mfg facilities they never used or couldn't get FDA qualified, sales volume was miserable even after they got EUA - and they're the only ones that are still not FDA approved - MRNA and PFE got full approval. The CEO got fired last year for incompetence - NVAX was the laughingstock of the biotech world for a while there because they couldn't do anything right. I can understand you dumping it, all they had in 2019 was a flu vaccine, and they actually finished that P3 several years ago, had decent results, but never filed an NDA - just bizarre. BTW, they had a 1:20 RS, not 1:10 - twice as bad.